Riskpilot← Back to searchSign inGet full accessBiowatch Holding ApS
APSActiveCVR 36562404Aurehøjvej 12All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 2015— employees
Revenue 2024
DKK -111K
-17% vs 2023
EBITDA margin
100.0%
+17% vs 2023
Equity ratio
99.2%
Financial strength
Net profit 2024
DKK -5,2M
-147% vs 2023
| Revenue | DKK -111K | -17% |
| EBITDA | DKK -111K | +17% |
| Net profit | DKK -5,2M | -147% |
| Total assets | DKK 3,7M | -59% |
| Equity | DKK 3,7M | -59% |
| Employees | — | — |
Legal name
Biowatch Holding ApS
CVR number
36562404
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
9. marts 2015
Share capital
DKK 176.109
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at i) udøve virksomhed
med udvikling og salg af tjenesteydelser
indenfor velfærdsteknologi, IT, mHealth, ii)
eje, investere i og sælge virksomheder med
de under (i) anførte formål og iii) dermed
beslægtet virksomhed.
Address
Aurehøjvej 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -11 | -96 | -13 | -97 | -13 | -15 | -7 | -127 | -134 | -111 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -11 | -96 | -13 | -97 | -13 | -15 | -7 | -127 | -134 | -111 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -11 | -96 | -13 | -97 | -13 | -15 | -7 | -127 | -134 | -111 |
| Net financials | -3 | -4 | -41 | -23 | -3 | -252 | -1.130 | -3.428 | -1.999 | -5.049 |
| Profit before tax | -14 | -101 | -53 | -120 | -16 | -267 | -1.138 | -3.555 | -2.133 | -5.160 |
| Tax | -2 | -22 | -4 | 28 | -0 | -0 | 31 | -26 | -23 | 50 |
| Net profit | -11 | -79 | -49 | -148 | -16 | -267 | -1.169 | -3.529 | -2.110 | -5.210 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 | 46 | 72 | 108 | 141 | 350 | 3.971 | 9.537 | 8.978 | 3.687 |
| Equity | -7 | -86 | -85 | -133 | -149 | -416 | 3.415 | 5.036 | 8.867 | 3.658 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.990 | 0 | 0 |
| Short-term debt | 12 | 133 | 158 | 241 | 290 | 766 | 555 | 511 | 110 | 29 |
| Total debt | 12 | 133 | 158 | 241 | 290 | 766 | 555 | 4.501 | 110 | 29 |
EBITDA margin
-11085200.0%
This company
15.8%
Market median
-70159594% vs market
20152024
Equity ratio
99.2%
This company
38.2%
Market median
+160% vs market
20152024
Return on equity
-142.4%
This company
18.4%
Market median
-874% vs market
20152024
Net profit margin
-520985200.0%
This company
8.1%
Market median
-6431916149% vs market
20152024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20152024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-03-09 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MT Management | Management | 2015 | — | — |
JC Management | Management | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
WESTEROS ApS | Company | 20.0% | 20.0% | 2024 |
Biowatch Friends ApS | Company | 15.0% | 15.0% | 2023 |
AN2020 ApS | Company | 10.0% | 10.0% | 2025 |
New Normal Labs ApS | Company | 10.0% | 10.0% | 2025 |
| Individual | 10.0% | 10.0% | 2025 | |
JKP HOLDING ApS | Company | 5.0% | 5.0% | 2023 |
Biowatch Holding ApS | Company | 5.0% | 5.0% | 2023 |
Fedelsborg Holding ApS | Company | 5.0% | 5.0% | 2021 |
MIBOSC Holding ApS | Company | 15.0% | 15.0% | 2021 |
JALP Holding ApS | Company | 20.0% | 20.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JKP HOLDING ApS
Biowatch Holding ApS Board members of Biowatch Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikkel Thykjær Jørgensen | Management | 0 companies |
| John Chuong Ly | Management | 0 companies |
| Claus-Henrik Rasmussen | Board of Directors | 0 companies |
| Martin Franke Amor | Board of Directors | 0 companies |
| Jannik Kruse Petersen | Board of Directors | 0 companies |
| Svend Tøttrup | Chairman | 0 companies |